Kamada (KMDA) Free Cash Flow Growth (3y) (2015 - 2026)
Kamada (KMDA) Free Cash Flow Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 14.41% |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 216.31% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 4.08% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 49.44% |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -10.40% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -9.38% |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 134.18% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Kamada | 473.85 Mn | 444.38 Mn | 22.47 Mn | 77.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 77.63% |
| Mar 31, 2026 | 633.92% |
| Dec 31, 2025 | 72.43% |
| Sep 30, 2025 | 1,153.66% |
| Jun 30, 2025 | -0.25% |
| Mar 31, 2025 | -45.74% |
| Dec 31, 2024 | 125.22% |
| Sep 30, 2024 | 185.13% |
| Jun 30, 2024 | 120.45% |
| Mar 31, 2024 | 18.35% |
| Dec 31, 2023 | -28.37% |
| Sep 30, 2023 | -11.73% |
| Jun 30, 2023 | -37.50% |
| Mar 31, 2023 | -26.01% |
| Dec 31, 2022 | -53.00% |
| Sep 30, 2022 | -89.86% |
| Jun 30, 2022 | 11.94% |
| Mar 31, 2022 | -2.07% |
| Dec 31, 2021 | -53.23% |
| Sep 30, 2021 | -39.76% |